Management of early diabetic nephropathy

The number of people with diabetes is increasing worldwide mainly because of an increase in Type 2 diabetes. Diabetes is now the leading cause of end-stage renal disease (ESRD) in Western countries. Diabetic kidney disease (nephropathy) has been reported to occur in 25-40% of people with Type 1 or Type 2 diabetes. People with diabetes, especially those with kidney complications, also face an increased risk of death from cardiovascular disease (CVD). Therefore, the early identification of people with diabetes at greatest risk, and the subsequent initiation of protective treatments are of the utmost importance. The good news for people with diabetes is that several successful prevention and treatment strategies for diabetic nephropathy and CVD have been described over the last 10 years.
Attachment: 
Keywords: 
Kidney, Nephropathy, CVD, Microalbuminuria, Risk factors, End-stage kidney disease, End-stage diabetic nephropathy, ESDN
Section: